1-Methyl-5-(4-methyl-1,3-thiazol-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione

Catalog No. :
ACXPSI384
CAS No. :
1221820-86-5
Molecular Formula :
C9H9N3O2S
Molecular Weight :
223.26

IUPAC Name:1-methyl-5-(4-methylthiazol-2-yl)pyrimidine-2,4(1H,3H)-dione

1-Methyl-5-(4-methyl-1,3-thiazol-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$407.00Login to see priceInquiryInquiry
5g95%$1183.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Methyl-5-(4-methyl-1,3-thiazol-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
IUPAC Name1-methyl-5-(4-methylthiazol-2-yl)pyrimidine-2,4(1H,3H)-dione
MDL No.MFCD13368191
Molecular FormulaC9H9N3O2S
Molecular Weight223.26
SMILESO=C1NC(C(C2=NC(C)=CS2)=CN1C)=O
InChI KeyFDMIAHXVJGSECA-UHFFFAOYSA-N
Synonym1-Methyl-5-(4-methyl-1,3-thiazol-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione;2,4(1H,3H)-Pyrimidinedione, 1-methyl-5-(4-methyl-2-thiazolyl)-
CAS No.1221820-86-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXPSI384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJQAU875 route compound structure diagram
    ACJQAU8757238-61-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXPSI384 route product structure diagram
    ACXPSI3841221820-86-5
Inquiry

2. ACXPSI384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXPSI384 route product structure diagram
    ACXPSI3841221820-86-5
Inquiry

Comments (0)